Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
326.20    -4.40 (-1.33%)
Bid:
325.60
Ask:
326.20
Spread: 0.60 (0.184%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Directorate Change

21 Aug 2019 07:00

RNS Number : 7001J
Hammerson PLC
21 August 2019
 

Hammerson plc (the "Company")

Board Change 

21 August 2019

 

Appointment of Chief Financial Officer

 

Hammerson plc announces the appointment of James Lenton as Chief Financial Officer ("CFO") and Executive Director.

 

James will become an Executive Director on joining the Company on 16 September 2019 and will take over the role of CFO with effect from 1 October 2019.

 

A Chartered Accountant, James has extensive experience in financing, rigorous capital allocation and business transformation, gained through senior roles at global financial and professional services organisations.

 

James joins Hammerson having recently left global insurer and investment business AIG, which he originally joined in 2013 as deputy CFO for EMEA. In 2014 he was promoted to CFO and board member1 of AIG's European Group, a position he held for four years, delivering new profitability and financing strategies for the £5bn revenue business.

 

Prior to AIG, James worked at EY (formerly Ernst & Young). In 2006 he was appointed Partner, providing a range of assurance and advisory services including M&A, financing and external audit. From 2011, he was responsible for developing a new global strategy for the Insurance Assurance practice. His clients included FTSE 100 companies and financial services groups with leading retail brands.

 

James succeeds Timon Drakesmith, the current CFO and Managing Director, Premium Outlets, who as announced in May 2019, has decided to leave the Company. Timon will step down as an Executive Director and CFO on 1 October 2019 and leave on 15 November 2019, following a handover and transition period with James.

 

The Company also recently announced that Simon Travis has been appointed to the role of Group Investment Director & Managing Director, Premium Outlets. Premium outlets now accounts for 27% of Hammerson's property portfolio and Simon reports directly to CEO, David Atkins.

 

David Tyler, Chair of the Board, said: "We look forward to welcoming James to the business. During his career he has demonstrated significant success in working with and managing complex organisations which are experiencing periods of substantial change. We expect his track record in this area, combined with his ability to bring a fresh perspective, to be very valuable to the on-going management and performance of Hammerson."

 

There are no further matters in connection with this appointment to be disclosed under Listing Rule 9.6.13.

 

1 Directorships effective, following regulatory approval, to principal operating companies in 2014 and to European Group holding company board in March 2015.

 

Notes to editors

·; James started his career at PwC, where he qualified as a Chartered Accountant in 2001.

·; At EY he become a Partner by the age of 30 in the EMEIA Financial Services Practice and was Global Co-ordinating Partner for the insurance assurance practice from 2011.

·; James is 44 and is married with two children and lives in south west London.

Remuneration terms for James Lenton

·; James will be paid in accordance with the Directors' Remuneration Policy approved by shareholders.

·; His annual salary will be £430,000 and his pension will be in line with that offered to Hammerson Group Management employees.

·; Upon joining, he will receive a prorated 2019 LTIP award in line with Hammerson's current remuneration policy.

·; There is no buyout of or compensation for previous remuneration packages.

·; Full details will be disclosed in the 2019 Directors' Remuneration Report.

 

ENDS

 

Julia Crane

Deputy Company Secretary

+44 (0) 20 7887 1000

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAURAWRKBAWUAR
Date   Source Headline
8th Jun 202612:15 pmRNSAdmission to Trading
8th Jun 202611:00 amRNSDirector/PDMR Shareholding
5th Jun 20268:00 amRNSPublication of Final Terms
2nd Jun 20267:00 amRNSSuccessful pricing of 5-year EUR350m bond
29th May 20263:45 pmRNSHolding(s) in Company
26th May 202610:00 amRNSResults of Dividend Reinvestment Plan
22nd May 20264:15 pmRNSDirector/PDMR Shareholding
19th May 20262:00 pmRNSDirector/PDMR Shareholding
15th May 202612:30 pmRNSDirector/PDMR Shareholding
14th May 20263:00 pmRNSDirector/PDMR Shareholding
30th Apr 20264:30 pmRNSTotal Voting Rights
30th Apr 202611:15 amRNSResult of AGM
30th Apr 20267:00 amRNSHammerson CFO to retire
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20263:00 pmRNSDirector/PDMR Shareholding
24th Apr 20261:30 pmRNSEMTN Programme: Publication of Base Prospectus
24th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSHolding(s) in Company
8th Apr 20264:00 pmRNSDirector/PDMR Shareholding
7th Apr 202612:45 pmRNSTotal Voting Rights and Capital
30th Mar 202610:00 amRNSDirector/PDMR Shareholding
26th Mar 202611:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20262:00 pmRNSDirector/PDMR Shareholding
17th Mar 202610:00 amRNSDirector/PDMR Shareholding
17th Mar 20269:00 amRNSDividend Currency Conversion Announcement
25th Feb 20267:01 amRNSDividend Declaration
25th Feb 20267:00 amRNSFinal Results
6th Feb 20267:00 amRNSDirectorate change
28th Jan 20269:00 amRNSNotice of Results
20th Jan 20263:30 pmRNSHolding(s) in Company
22nd Dec 202511:30 amRNSDirector/PDMR Shareholding
22nd Dec 20259:30 amRNSDirector/PDMR Shareholding
15th Dec 20253:00 pmRNSDirector/PDMR Shareholding
11th Dec 20252:15 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSDirectorate change
21st Nov 20257:00 amRNSAcquisition of The Oracle and Trading Update
13th Nov 20251:45 pmRNSDirector/PDMR Shareholding
31st Oct 20257:45 amRNSResults of Dividend Reinvestment Plan
28th Oct 20251:00 pmRNSDirector/PDMR Shareholding
24th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 202511:00 amRNSDirector/PDMR Shareholding
22nd Oct 20254:30 pmRNSDirector/PDMR Shareholding
21st Oct 202512:00 pmRNSDirector/PDMR Shareholding
16th Oct 20251:00 pmRNSPublication of Final Terms
9th Oct 20257:00 amRNSBond Pricing, Guidance & Operational Update
25th Sep 20254:30 pmRNSHolding(s) in Company
19th Sep 20253:30 pmRNSDirector/PDMR Shareholding
11th Sep 20254:45 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSAppointment of Rob Wilkinson as CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.